CINCINNATI, December 30, 2021 (GLOBE NEWSWIRE) – Quipt Home Medical Corp. (“joke“or the”Society“) (NASDAQ: QIPT; TSXV: QIPT), a U.S. home medical equipment industry leader focused on end-to-end respiratory care, announces that, following its December 16, 2021 press release, its request for a cease trade order from the management (the “MCTO”) Under national policy 12-203 – Management discontinuation Commercial orders (“NP 12-203“) has been approved by the British Columbia Securities Commission (“BCSC“). The MCTO does not affect the ability of investors (other than management) to trade in the securities of the Company.

The Company announced on December 16, 2021 (the “Default ad“) that he was filing an MCTO application with the BCSC because he was likely to miss his December 29, 2021 filing deadline to file his annual financial statements and MD&A for the years ended September 30, 2021 and 2020, and CEO and CFO certificates, the whole as required by NI 51-102 and NI 52-109 (collectively, the “Documents“). The delay in filing the documents is due, in part, to the expedited deadline for the company to complete the documents due to the listing of its common shares for trading on the Nasdaq Capital Market and on the expedited basis according to which the company’s auditors had to complete the audit. The Company continues to work diligently and expeditiously with its auditors and plans to file the Documents as soon as possible but no later than its historic deadline of January 28, 2022.

The MCTO restricts trading in the securities of the Company by management of the Company until the Documents have been filed by the Company and the MCTO is no longer in effect.

Until the Company has filed the Documents, members of the management of the Company and other insiders are subject to an insider trading blackout in accordance with its insider trading policy. The Company confirms that, except as disclosed in previous press releases and material change reports, there has been no material business development since the filing of the Company’s last interim financial report.

The Company is not currently the subject of any insolvency proceedings. If the Company provides information to any of its creditors during the period in which it is in default of filing documents, the Company confirms that it will also file material change reports on SEDAR containing the required information.

The Company confirms that since the date of the default announcement: (i) there has been no material change to the information set out in the default announcement which has not been generally disclosed; (ii) the Company satisfies and confirms that it intends to continue to meet the provisions of the Alternative Disclosure Guidelines under NP 12-203 and to issue default status reports both weeks as the delay in filing documents continues, each to be issued as a press release; (iii) there has been no other defect specified by the Company under PN 12-203; (iv) the Company is not the subject of any insolvency proceedings; and (v) there is no material information relating to the affairs of the Company which has not been generally disclosed.

ON LEAVE RESIDENCE MEDICAL CORP.

The Company provides home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic diseases with a focus on patients with heart or lung disease, sleep disorders, reduced mobility and other chronic health conditions. The Company’s primary business objective is to create shareholder value by providing a broader range of services to patients requiring home care and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating patient services and making their lives easier.

No more the TSX Business Exchange or his Regulation Services Provider (like this term is defined in the Strategies of the TSX Business Exchange) accepted responsibility for the adequacy Where precision of this Release.

Looking to the future Statements

Certain statements contained in this press release constitute “forward-looking information” as that term is understood. defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “possible”, “Will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions relate to the Company, including statements regarding when the Documents are filed, are intended to identify forward-looking information. All statements other than statements of historical fact may to be looking to the future information. Phone statements reflect the of the company running views and intentions with respect future events and current information available to the Company, and are subject to certain risks, uncertainties and hypotheses. Many factors could cause the current results, performance Where achievements that Maybe expressed or implied by such forward-looking information to differ from that described in this document if one or more of these risks or uncertainties materialize. Examples of such risk factors include, but are not limited to: credit; market (including stocks, commodities, currencies and interest rates); liquidity; operational (including Technology and Infrastructure); reputational; Assurance; strategic; regulatory; legal; environmental; Capital city adequacy; general commercial and economic conditions in the regions in which the Company operates; the aptitude of the Society at execute to key priorities, including the to success completion of acquisitions, Business retention and strategic plans and to attract, develop and retain key executives; difficulty integrating newly acquired businesses; the ability to implement business strategies and seek business opportunities; low profit Market segments; disruptions or attacks (including cyberattacks) on the Company’s information technologies, Internet, network access or other voice or data communication systems or services; the evolution of various types of fraud or other criminal behavior to which the Company is exposed; non-compliance by third parties with their obligations to the Company or its affiliates; the impact of new and changes or the application of, the laws and regulations in force; lower reimbursement rates; dependence on a few payers; possible new drug discoveries; a new business model; dependence on key suppliers; the granting of permits and licenses in a regulated business; the difficult global litigation environment, including in the United States; increased competition; changes in exchange rates; increased funding costs and market volatility due to market illiquidity and competetion for funding; the availablity of funds and Resources at to chase operations; critical accounting estimates and changes in accounting standards, policies and methods used by the Company; the occurrence of natural and unnatural catastrophic events and claims resulting from such events; and risks associated with COVID-19 including various recommendations, orders and measures of government authorities at to try at limit the pandemic, including to travel restrictions, frontier closures, not essential Business closures, quarantines, self-isolation, shelter in place and social distancing, market disruption, economic activity, financing, supply chains and sales channels, and a deterioration in general economic conditions, including a possible national or global recession; as well as the risk factors discussed or mentioned in the Company’s disclosure documents filed with the United States Securities and Exchange Commission and available at www.sec.gov, and with the titles regulatory authorities in certain provinces of Canada and available at www.sedar.com. Should any factor affects the Company in an unexpected way, or if the underlying assumptions information to prove Incorrect, the real results Where events may differ materially from the results Where events predicted. Any Phone looking to the future information is expressly qualified in his entirety through this precautionary declaration. In addition, the Company assumes no responsibility for the accuracy or completeness of these forward-looking information. The forward-looking information included in this press release is made as of the date of Dated of this hurry Release and the Society commits no obligation at publicly update Where revise any looking to the future information, other that like obligatory by applicable law.

For more information, please visit our website at www.Quipthomemedical.com, or contact:

Cole stevens
Vice President of Corporate Development
Quipt Home Medical Corp.
859-300-6455
[email protected]

Gregory Crawford
Chief executive officer
Quipt Home Medical Corp.
859-300-6455
[email protected]